METRONOMIC CAPECITABINE AS SALVAGE CHEMOTHERAPY IN PRETREATED PATIENTS WITH ADVANCED GASTROINTESTINAL CANCER (AGIC)

被引:0
|
作者
Barucca, V
Romiti, A.
Sarcina, I
Di Rocco, R.
Morelli, F.
Durante, V
Marchetti, P.
机构
[1] Univ Roma La Sapienza, St Andrea Hosp, Rome, Italy
[2] IDI IRCS, Rome, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:112 / 112
页数:1
相关论文
共 50 条
  • [41] CLINICAL IMPACT OF METRONOMIC ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER
    Fujihara, Miwa
    Ohtani, Shoichiro
    Ito, Mistuya
    Kajiwara, Yukiko
    Yoshimura, Yuri
    BREAST, 2015, 24 : S40 - S40
  • [42] Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients
    Valenzuela, Paloma
    Oaxaca, Derrick
    Di Desidero, Teresa
    Parra, Karla
    Rodriguez, Georgialina
    Manciu, Marian
    Allegrini, Giacomo
    Falcone, Alfredo
    Bocci, Guido
    Kirken, Robert A.
    Francia, Giulio
    CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (01) : 149 - 159
  • [43] Pharmacodynamic biomarkers in metronomic chemotherapy: Multiplex cytokine measurements in gastrointestinal cancer patients
    Valenzuela, Paloma
    Parra, Karla
    Oaxaca, Derrick
    Reza, Luis
    Lopez, Jose
    Arreguin, Montserrat Garcia
    Garcia, Diana
    Rodriguez, Georgialina
    Falcone, Alfredo
    Allegrini, Giacomo
    Di Desidero, Teresa
    Bocci, Guido
    Kirken, Robert
    Francia, Giulio
    CANCER RESEARCH, 2017, 77
  • [44] Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes
    Yao, Guangyu
    Cao, Li
    Liu, Mingfeng
    Chen, Lujia
    Hu, Xiaolei
    Ye, Changsheng
    CHEMOTHERAPY, 2015, 61 (04) : 171 - 178
  • [45] A multicenter randomized study comparing vinorelbine plus gemcitabine versus capecitabine monotherapy as salvage treatment in patients with advanced breast cancer pretreated with taxane and anthracycline chemotherapy: A preliminary report.
    Mavroudis, D.
    Ardavanis, A.
    Boukovinas, I.
    Varthalitis, I.
    Syrigos, K.
    Potamianou, A.
    Kouroussis, C.
    Georgoulias, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 42S - 42S
  • [46] Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study
    Brandi, Giovanni
    de Rosa, Francesco
    Agostini, Valentina
    di Girolamo, Stefania
    Andreone, Pietro
    Bolondi, Luigi
    Serra, Carla
    Sama, Claudia
    Golfieri, Rita
    Gramenzi, Annagiulia
    Cucchetti, Alessandro
    Pinna, Antonio Daniele
    Trevisani, Franco
    Biasco, Guido
    ONCOLOGIST, 2013, 18 (12): : 1256 - 1257
  • [47] Metronomic capecitabine in the advanced patients with hepatocellular carcinoma (HCC): Preliminary results
    Brandi, G.
    Fanello, S.
    Piscaglia, F.
    Falanga, A.
    Bolondi, L.
    Flori, S.
    Derenzini, E.
    Palassini, E.
    Fedele, M.
    Biasco, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] METRONOMIC ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER: A SINGLE INSTITUTION EXPERIENCE
    Takao, Shintaro
    Tane, Kaori
    Hirokaga, Kouichi
    Maekawa, Youko
    BREAST, 2011, 20 : S47 - S47
  • [49] Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer
    Franchi, F.
    Grassi, P.
    Ferro, D.
    Pigliucci, G.
    De Chicchis, M.
    Castigliani, G.
    Pastore, C.
    Seminara, P.
    EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (03) : 258 - 262
  • [50] Selection of candidates for oral etoposide salvage chemotherapy in heavily pretreated breast cancer patients
    Jagodic, M
    Cufer, T
    Zakotnik, B
    Cervek, J
    ANTI-CANCER DRUGS, 2001, 12 (03) : 199 - 204